Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease.

Abstract

Huaquan Wang1, Guangsheng He2, Jinsong Jia3, Mengyuan Liu1, Hui Liu1, Ting Wang1, Chunyan Liu1, Rong Fu1 1Department of Hematology, General Hospital, Tianjin Medical University, Tianjin 300052, China; 2Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing 210029, Jiangsu Province, China; 3Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China